Research Site US020 — Durham, North Carolina

Research Site US020 is a clinical research site located in Durham, North Carolina, United States 27710.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Research Site US020 has participated in 2 clinical trials.

Therapeutic areas: Respiratory Syncytial Virus (RSV), Respiratory Syncytial Virus Infections.

Sponsors: Novavax.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Site US020?

Research Site US020 has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Site US020 conducted?

Research Site US020 has 2 clinical trials on record. Their work covers Respiratory Syncytial Virus (RSV), Respiratory Syncytial Virus Infections.

Is Research Site US020 accredited by Crixeo Health?

Research Site US020 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Research Site US020?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.